Instituto de Ensino e Pesquisa do Hospital da Bahia

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Heart failure1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen1 trial
• Boehringer Ingelheim1 trial

Running trials

• Active, not recruiting

  Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

  NCT05740566· Phase 3· Amgen· Source

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source